IMV INC (IMV) Stock News

NASDAQ:IMV - Nasdaq - CA44974L3011 - Common Stock - Currency: USD

0.8225 -0.02 (-2.55%)

After market: 0.8 -0.02 (-2.74%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

IMV Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Receives NASDAQ Delisting Notice

2 years ago - By: Horizon Technology Finance Corporation - Mentions: HRZN

News Image

Horizon Technology Finance Announces First Quarter 2023 Financial Results

2 years ago - By: Seeking Alpha

IMV stock cut to Neutral at H.C. Wainwright (NASDAQ:IMV)

2 years ago - By: Benzinga - Mentions: GOOS ROP ZS TDC ...

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023

2 years ago - By: Benzinga

IMV's Earnings: A Preview

2 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Initiates Restructuring Proceedings Under the CCAA to Complete the Review of its Strategic Alternatives

2 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

2 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Inc. Announces Changes to Its Board of Directors

2 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Inc. Announces Strategic Update as well as Fourth Quarter and Full Year 2022 Financial and Operational Results

2 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023

2 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Inc. Presents Positive Initial Results From The MVP-S Phase 2B VITALIZE Trial

3 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Inc. Announces Update and Planned 2023 Milestones to Advance Clinical Development of its Lead Therapeutic, MVP-S

3 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Announces Closing of US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

3 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Announces US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

3 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Inc. Announces Initial Data from the Ongoing Phase 2B VITALIZE Trial in Patients with r/r DLBCL

3 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Commences Trading on the TSX and Nasdaq Post-Reverse Stock Split

3 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Shareholders Approve Reverse Stock Split at 88%

3 years ago - By: Seeking Alpha

IMV receives Nasdaq notification of deficiency (NASDAQ:IMV)

3 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Receives Nasdaq Notification Regarding Market Value of Listed Securities

3 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Inc. Announces Third Quarter 2022 Financial and Operational Results

3 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Inc. to Announce Third Quarter 2022 Results and Host a Conference Call and Webcast on November 11, 2022

3 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Provides an Update on The VITALIZE Trial

3 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Inc. Announces Strategic Reorganization

3 years ago - By: IMV Inc. - Mentions: IMV.CA

IMV Inc. to Present at Two Investor Conferences in September